Technical validation of an autoantibody test for lung cancer.
about
Development and validation of a high throughput system for discovery of antigens for autoantibody detectionAdvances in proteomic strategies toward the early detection of lung cancerSerum autoantibody measurement for the detection of hepatocellular carcinomaTumor-associated autoantibodies as diagnostic and prognostic biomarkers.Prognostic and diagnostic value of spontaneous tumor-related antibodiesApplication of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung TestClinical validation of an autoantibody test for lung cancer.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Human Blood Autoantibodies in the Detection of Colorectal Cancer.EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays.Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer.Multiplexed Serum Biomarkers for the Detection of Lung Cancer.The Pursuit of Noninvasive Diagnosis of Lung Cancer.Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.BARD1 serum autoantibodies for the detection of lung cancer.Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.Screening and early detection of lung cancer.Serum GFAP autoantibody as an ELISA-detectable glioma marker.Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.Liquid biopsy for early stage lung cancer.Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.Spontaneous antibodies against Engrailed-2 (EN2) protein in patients with prostate cancer
P2860
Q28729058-4980207B-7423-4B9C-BACA-08B44C377F08Q31008766-807A8568-67BD-4658-9325-13C38BEAC9A8Q34004797-F1064696-F7CA-42CD-870A-8E093A03E4BFQ34049184-AC0154E3-9581-449F-8C59-FF14B80B2853Q34475795-5D5DF64C-6B7D-4967-9430-91E33EFFA3DDQ34525089-71C62ACE-0102-4989-8260-60EE49E958B0Q34537374-2F57FB8A-7062-499E-9917-2133223AF1F5Q35104929-7DABA8F2-92B8-4F59-ABB9-A461A70E5187Q36068902-5E922A6D-0172-4FF3-A41F-34CD00DD628BQ36285345-28C7ED3E-60BC-4D1A-A53C-58023904CE25Q36464730-89A7953E-8EED-47CC-8D05-3A0CEA864C3FQ37274622-D835838C-665D-4363-9314-120137C8AB80Q37309658-35F88FAA-6E8A-4219-A231-84AF67E5A7EAQ37652904-4067F70F-4156-42DB-B496-EEF377F0A4DAQ37721848-AAFEDAFF-E502-4896-8A2E-2E9DE1C327F9Q38172914-171DA75E-4B66-4289-B5AA-CEB4D2DC2E2EQ41281453-F886D362-0E79-4FDC-BEC9-3873BB87219BQ41294153-47722413-152F-401C-8BA4-3400F71A5199Q42668610-692396F9-CA04-4258-9B7E-6A493E9E141EQ51066755-FCE4CDB6-7C93-4B57-8CE2-7C2510B4A372Q51331951-92D9B2C6-4150-4173-84D4-839B1F1FCF1DQ54962725-ED7B5FD2-99A1-4308-B3E7-E0DCF1FA6330Q55031677-1C2A5A24-6A0E-4FC8-B82E-618C247700F0Q55346824-58354BDD-9B09-408D-BB53-08791B3F2153Q57694335-29529BF0-2DAF-4392-84F4-C93868A70D2C
P2860
Technical validation of an autoantibody test for lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Technical validation of an autoantibody test for lung cancer.
@ast
Technical validation of an autoantibody test for lung cancer.
@en
Technical validation of an autoantibody test for lung cancer.
@nl
type
label
Technical validation of an autoantibody test for lung cancer.
@ast
Technical validation of an autoantibody test for lung cancer.
@en
Technical validation of an autoantibody test for lung cancer.
@nl
prefLabel
Technical validation of an autoantibody test for lung cancer.
@ast
Technical validation of an autoantibody test for lung cancer.
@en
Technical validation of an autoantibody test for lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Technical validation of an autoantibody test for lung cancer.
@en
P2093
C J Chapman
H A Fritsche
H F Sewell
J F R Robertson
P2860
P304
P356
10.1093/ANNONC/MDP606
P577
2010-02-02T00:00:00Z